Key result
Surgical mitral valve replacement and tricuspid valve reconstruction successfully treated active infective endocarditis following MitraClip implantation, with no major postoperative complications.
Case Report (n=1)
Answers are grounded in this paper and cite their sources.
Surgical valve replacement can be successfully performed in patients with infective endocarditis following percutaneous edge-to-edge mitral valve repair despite high predicted surgical risk.
A 57-year-old man with ischaemic cardiomyopathy was admitted to our institution with fever. The patient had undergone percutaneous mitral valve repair abroad 2 weeks before admission. Transthoracic and transoesophageal echocardiography (TTE/TEE) were performed, showing a mobile lesion (red arrows) originating from the implanted MitraClip mitral valve repair system (*). Staphylococcus aureus was detected in all six serial blood cultures. Therefore, the diagnosis of infective endocarditis was definite. Antibiotic therapy (Vancomycin, Gentamicin, Rifampicin) was initiated immediately after echocardiography and obtaining blood cultures. Owing to clinical deterioration and increasing vegetation (initial size: 8 mm, size after 1 week: 12 mm), despite predicted high perioperative mortality (EuroScore: 18, mortality 79.3%), surgical treatment was considered. Mitral valve replacement using a biological prosthesis (St Jude Epic Mitral 31 mm) and tricuspid valve reconstruction were performed 8 days after admission. Intraoperative surgical and histological findings of the mitral valve and the attached MitraClip® confirmed the diagnosis of infective prosthetic endocarditis. Fortunately, no major postoperative complications occurred. Antibiotic therapy was continued for 6 weeks.
No takes yet. Share an insight, caveat, or question.
Kluge et al. (2011) conducted a case report in Infective prosthetic endocarditis (n=1). Surgical mitral valve replacement and tricuspid valve reconstruction was evaluated. Surgical mitral valve replacement and tricuspid valve reconstruction successfully treated active infective endocarditis following MitraClip implantation, with no major postoperative complications.
Synapse has enriched 10 related papers. Consider them for comparative context: